Clinical trial in Japan
HOME > Business Services > DMAH Service

DMAH Services

Role of a Marketing Authorization Holder(MAH)

The applicant of submissions for medical device approvals/certifications must have an appropriate business license; Marketing Approval Holder (MAH), according to the Japanese Pharmaceutical Affairs Law. Since only companies registered in Japan can obtain the MAH license, overseas manufacturers must appoint a Japanese company who has the license, as the MAH. Then, the MAH will maintain the medical device approval and registration process. When the medical device is approved and is marketed in Japan, the MAH will act as the representative organization in Japan, and the MAH must have responsibilities of GVP and GQP.
There are two ways to appoint MAH for overseas manufacturers; MAH or DMAH.


What are differences among DMAH and MAH?

MAH: Marketing Authorizationt Holder

DMAH: Designated Marketing Authorization Holder

Rolls/tasks of MAH and DMAH are almost same, such as responsibilities of GVP and GQP. But there are some differences among MAH and DMAH as mentioned in above. Therefore, it should be determined carefully, considering environment and situation of your company and your business partner (ie; subsidiary in Japan, reliability and possibility of your partner in Japan etc.)

Japan MDC is licensed as a Medical Device Marketing Authorization Holder (1st-class MAH), and provides consultation services related to the acquisition of the above licenses for companies registered in Japan.
As such, we can also work as a professional, independent DMAH for your company in Japan.
If you are thinking a distribution in Japan, we would recommend our DMAH Service as one option.


Don't hesitate to contact us concerning any questions which may arise.


Japan MDC's DMAH Service Flow

GCP audit
▲ page top